Theranos $44,000,000 Settlement for Fraudulent Blood Testing Services

Theranos has agreed to pay $44,000,000 to settle a class action lawsuit for alleged fraudulent blood testing services marketed to consumers in Walgreens retail stores in Arizona and California. This settlement aims to compensate affected consumers who purchased Theranos blood testing services between November 2013 and June 2016.

Who Benefits?: All purchasers of Theranos testing services, including those who paid out-of-pocket, through health insurance, or through any other source, between November 2013 and June 2016.

How much can I get?: Class Members will receive payments based on the costs of their Theranos blood testing services, with some adjustments. Members of the Walgreens Edison Subclass will receive an additional payment.

Important Dates

• Fairness Hearing: The Fairness Hearing was held on February 6, 2024.
• Deadline to File a Claim: Eligible Class Members do not need to file a claim to receive payment.

Can I Claim an Award?

To be eligible for a settlement award, you must be a purchaser of Theranos testing services between November 2013 and June 2016. This includes consumers who paid out-of-pocket, through health insurance, or through any other source. The Class is further divided into three Subclasses: the Arizona Subclass, the California Subclass, and the Walgreens Edison Subclass.

The Arizona Subclass includes all purchasers of Theranos testing services in Arizona between November 2013 and June 2016. The California Subclass includes all purchasers of Theranos testing services in California between September 2013 and June 2016. The Walgreens Edison Subclass includes all purchasers of Theranos testing services who were subjected to 'tiny' blood draws (fingerpricks) by a Walgreens employee between November 2013 and March 2015.

• Class: All purchasers of Theranos testing services between November 2013 and June 2016.
• Arizona Subclass: All purchasers of Theranos testing services in Arizona between November 2013 and June 2016.
• California Subclass: All purchasers of Theranos testing services in California between September 2013 and June 2016.
• Walgreens Edison Subclass: All purchasers of Theranos testing services who were subjected to 'tiny' blood draws (fingerpricks) by a Walgreens employee between November 2013 and March 2015.

Section Detailing the Award(s) Class Members Can Claim

Under the proposed Plan of Allocation, there are two types of payments under the Walgreens settlement: the 'Class Member Payment' and the 'Walgreens Edison Subclass Member Payment'.

Each Class Member will receive a Class Member Payment based on the unreimbursed costs of their Theranos blood testing services according to Theranos’s customer records. This includes a Base Payment of $10.00 plus two times the total costs of their Theranos blood testing services during the Class period, minus any refunds already received from the 2017 Arizona Attorney General Consent Decree with Theranos.

• Class Member Payment: A Base Payment of $10.00 plus two times the total costs of their Theranos blood testing services during the Class period, minus any refunds already received.
• Walgreens Edison Subclass Member Payment: An additional flat amount, currently estimated to be between approximately $700 and $1,000, as compensation for battery and medical battery claims.

Theranos Blood Testing Services: The Heart of the Settlement

The settlement revolves around Theranos blood testing services, which were marketed to consumers in Walgreens retail stores in Arizona and California. These services were alleged to be unreliable and not market-ready, leading to the class action lawsuit.

• Theranos blood testing services
• Walgreens retail stores in Arizona and California

Is Proof Required to Claim the Reward?

No proof is required to claim the reward. The Settlement Administrator will calculate the settlement payment amounts based on Theranos’s customer records.

How to Claim Your Award

Eligible Class Members do not need to file a claim to receive a settlement payment. The Settlement Administrator will automatically calculate and distribute the payments. To ensure prompt and accurate delivery, you may update your address information at .

If your contact information has changed, you can update it by visiting the provided URL or by contacting the Settlement Administrator via email or phone.

$44,000,000 Settlement

The settlement amount is $44,000,000, which will be paid by Walgreens into a Settlement Fund. This fund will be used to pay Class Members, cover the costs of distributing notice and settlement payment checks, and other administrative expenses.

In addition to the $44,000,000 paid by Walgreens, approximately $1.33 million in additional settlement funds will be provided by the Theranos ABC. This will increase the amount of money available for distribution to the Class Members.

Why is There a Class Action Settlement?

The class action settlement was reached to resolve claims that Theranos blood testing services were unreliable and not market-ready. The settlement aims to compensate affected consumers and avoid the expense, uncertainty, and risks associated with litigation.

Next steps include the distribution of settlement payments to eligible Class Members. The Settlement Administrator will handle the calculation and distribution of payments based on Theranos’s customer records.